Vivint Pharma to establish state-of-the-art facility in Hyderabad’s Genome Valley with ₹400 crore investment

The new facility envisages job potential of 1,000

Leave a Reply

Your email address will not be published. Required fields are marked *

0 Comments
scroll to top